Innovex International
Valuation each multiple against its own 5-year range
Vs. peers Oil & Gas Equipment & Services
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Innovex International (INVX) | 1.57B | 31.93 | 1.40 | 0.00% |
| SLB Ltd (SLB) | 67.73B | 22.28 | 2.60 | 2.55% |
| Baker Hughes (BKR) | 44.50B | 15.40 | 2.21 | 2.05% |
| Tenaris (TS) | 27.85B | 14.15 | 1.65 | 3.23% |
| Halliburton (HAL) | 25.25B | 12.83 | 2.27 | 2.23% |
| TechnipFMC (FTI) | 22.83B | 18.46 | 6.85 | 0.34% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 24.5% below Morningstar's fair value estimate.
Fair value
Innovex International Inc is assigned a 4-star quantitative star rating, reflecting our opinion that this share class offers a somewhat attractive opportunity for investors. The stock currently trades at a 9% discount to our quantitative fair value estimate of $27.83 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.
The company's profitability strengthens our fair value estimate. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. Reflecting the firm's profitability is its earnings yield of 5.2%, which falls in the top 45% compared with global peers. This suggests that it is generating substantial earnings relative to its share price, which contributes to our view that shares are cheap.
Alternatively, the firm's unfavorable dividend structure is potentially concerning. Dividends represent a stable form of future cash flows returned to shareholders, and low dividend payments can increase the perceived risk of a business. The firm's forward dividend yield of 0%, for example, lies in the bottom 30% globally. This could imply a planned dividend cut or relatively high share price, which, despite our favorable price/fair value ratio, is a negative attribute.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.
Economic moat
With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-11-20 16:00:07 · For reference only, not investment advice and not tailored to your situation.
Innovex International discussion 0 comments